Pacira BioSciences
PCRX
205 hedge funds and large institutions have $3.58B invested in Pacira BioSciences in 2015 Q1 according to their latest regulatory filings, with 41 funds opening new positions, 75 increasing their positions, 71 reducing their positions, and 36 closing their positions.
14% more first-time investments, than exits
New positions opened: 41 | Existing positions closed: 36
3% more funds holding
Funds holding: 200 → 205 (+5)
6% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 71
3% more capital invested
Capital invested by funds: $3.48B → $3.58B (+$102M)
0% more call options, than puts
Call options by funds: $27.4M | Put options by funds: $27.4M
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Westfield Capital Management
Boston,
Massachusetts
|
+$73.9M |
| 2 |
JHIU
Janus Henderson Investors US
Denver,
Colorado
|
+$57.4M |
| 3 |
MCM
Marsico Capital Management
Denver,
Colorado
|
+$27.4M |
| 4 |
SI
Standard Investments
New York
|
+$27.1M |
| 5 |
PC
PointState Capital
New York
|
+$23.3M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCGI
Next Century Growth Investors
Plymouth,
Minnesota
|
-$30.8M |
| 2 |
Bank of New York Mellon
New York
|
-$21.8M |
| 3 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$18.5M |
| 4 |
CCI
Columbus Circle Investors
|
-$16.7M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
-$14.9M |
PCRX Hedge Fund Activity: Q1 2015 in Review
205 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in Pacira BioSciences (PCRX) for Q1 2015, worth a combined $3.58B — up 2.9% from $3.48B a quarter earlier.
Buyers outnumbered sellers: 41 funds opened new PCRX positions and 36 closed out — a net gain of 5 holders — while 75 added to existing stakes and 71 trimmed.
The largest buyer was Westfield Capital Management, opening a new position worth an estimated $73.9M. The largest seller was Next Century Growth Investors, cutting an estimated $30.8M.
- 205 institutional investors held Pacira BioSciences (PCRX) as of Q1 2015, up from 200 in Q4 2014.
- Funds reported $3.58B of Pacira BioSciences stock for Q1 2015, up 2.9% quarter-over-quarter.
- 41 funds opened new Pacira BioSciences positions in Q1 2015 and 36 closed out, a net change of +5 holders.
- The largest Pacira BioSciences buyer in Q1 2015 was Westfield Capital Management, an estimated $73.9M added.
- The largest Pacira BioSciences seller in Q1 2015 was Next Century Growth Investors, an estimated $30.8M sold.
Based on aggregated 13F filings for Q1 2015.